Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey. Show more

Location: 2 Headquarters Plaza, Morristown, NJ, 07960, United States | Website: https://ir.whitehawktx.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

85.3M

52 Wk Range

$1.39 - $3.81

Previous Close

$1.81

Open

$1.80

Volume

28,791

Day Range

$1.80 - $1.83

Enterprise Value

-91.9M

Cash

177.2M

Avg Qtr Burn

-23.89M

Insider Ownership

12.43%

Institutional Own.

68.55%

Qtr Updated

06/30/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date